Early Detection of Triple Negative Breast Cancer Relapse

Conditions: Triple Negative Breast Cancer Interventions: Diagnostic Test: ctDNA monitoring; Diagnostic Test: 68Ga-FAPI-46-PET-CT Sponsors: Institut Curie; National Research Agency, France; Roche Pharma AG Not yet recruiting

https://clinicaltrials.gov/study/NCT06225505

Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials